Jeanne Erdmann

1.6k total citations
32 papers, 1.3k citations indexed

About

Jeanne Erdmann is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jeanne Erdmann has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Jeanne Erdmann's work include Bone Metabolism and Diseases (8 papers), Cancer Genomics and Diagnostics (5 papers) and Bone health and treatments (4 papers). Jeanne Erdmann is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Cancer Genomics and Diagnostics (5 papers) and Bone health and treatments (4 papers). Jeanne Erdmann collaborates with scholars based in United States, Italy and Canada. Jeanne Erdmann's co-authors include Steven L. Teitelbaum, Yousef Abu‐Amer, F. Patrick Ross, Marisol Quiroz, M. Mehrdad Tondravi, Scott R. McKercher, R. Maki, Kenton L. Anderson, Kevin P. McHugh and Kurt D. Merkel and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Jeanne Erdmann

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeanne Erdmann United States 14 819 498 298 226 191 32 1.3k
J Lawry United Kingdom 21 482 0.6× 469 0.9× 161 0.5× 212 0.9× 238 1.2× 45 1.4k
Alfie Tsay United States 5 626 0.8× 375 0.8× 140 0.5× 147 0.7× 110 0.6× 6 1.1k
Zhenxin Shen United States 16 527 0.6× 371 0.7× 165 0.6× 97 0.4× 79 0.4× 30 1.1k
Carole A. MacKay United States 22 1.0k 1.3× 519 1.0× 91 0.3× 137 0.6× 123 0.6× 38 1.4k
K. Yamaguchi Japan 10 835 1.0× 591 1.2× 104 0.3× 83 0.4× 144 0.8× 22 1.2k
Kent Søe Denmark 27 1.2k 1.5× 788 1.6× 132 0.4× 156 0.7× 233 1.2× 62 1.8k
Mika Mulari Finland 13 1.1k 1.3× 700 1.4× 107 0.4× 83 0.4× 131 0.7× 16 1.5k
Atsushi Yamada Japan 19 700 0.9× 262 0.5× 99 0.3× 137 0.6× 185 1.0× 63 1.2k
J. Owens United Kingdom 12 967 1.2× 701 1.4× 65 0.2× 166 0.7× 219 1.1× 15 1.2k
Michael T. Engsig Denmark 8 880 1.1× 563 1.1× 107 0.4× 83 0.4× 420 2.2× 9 1.4k

Countries citing papers authored by Jeanne Erdmann

Since Specialization
Citations

This map shows the geographic impact of Jeanne Erdmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanne Erdmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanne Erdmann more than expected).

Fields of papers citing papers by Jeanne Erdmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanne Erdmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanne Erdmann. The network helps show where Jeanne Erdmann may publish in the future.

Co-authorship network of co-authors of Jeanne Erdmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanne Erdmann. A scholar is included among the top collaborators of Jeanne Erdmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanne Erdmann. Jeanne Erdmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdmann, Jeanne. (2017). Genetics: A clearer view. Nature. 551(7679). S44–S45. 1 indexed citations
2.
Erdmann, Jeanne. (2016). Trace elements: Innovative biopsy programs map how cancer spreads. Nature Medicine. 22(9). 963–965. 2 indexed citations
3.
Erdmann, Jeanne. (2013). Telltale hearts. Nature Medicine. 19(11). 1361–1364. 3 indexed citations
4.
Erdmann, Jeanne. (2012). Sequencing cells one at a time offers singular insight into cancer. Nature Medicine. 18(6). 842–842. 3 indexed citations
5.
Erdmann, Jeanne. (2011). Next Generation Technology Edges Genome Sequencing toward the Clinic. Chemistry & Biology. 18(12). 1513–1514. 4 indexed citations
6.
Erdmann, Jeanne. (2011). Broad Collaborations Bring New Energy to Autism Therapeutics. Chemistry & Biology. 18(2). 142–143. 2 indexed citations
7.
Erdmann, Jeanne. (2011). ISTO Technologies Aims to Rescue Damaged Joints. Chemistry & Biology. 18(3). 275–276. 5 indexed citations
8.
Erdmann, Jeanne. (2010). Chasing HIV from Its Hiding Place. Chemistry & Biology. 17(8). 787–788. 1 indexed citations
9.
Erdmann, Jeanne. (2010). Engineered Thrombin Aims to Take on Heparin. Chemistry & Biology. 17(12). 1267–1268. 3 indexed citations
10.
Erdmann, Jeanne. (2005). Researchers Facing Increasing Costs for Clinical Research, With Few Solutions. JNCI Journal of the National Cancer Institute. 97(20). 1492–1494. 5 indexed citations
11.
Clohisy, John C., Steven L. Teitelbaum, Shaoping Chen, Jeanne Erdmann, & Yousef Abu‐Amer. (2002). Tumor necrosis factor‐α mediates polymethylmethacrylate particle‐induced NF‐κB activation in osteoclast precursor cells. Journal of Orthopaedic Research®. 20(2). 174–181. 57 indexed citations
12.
Ross, F. Patrick, et al.. (2000). Tumor Necrosis Factor α Regulatesα vβ5 Integrin Expression by Osteoclast Precursors in Vitro and in Vivo1. Endocrinology. 141(1). 284–290. 35 indexed citations
13.
Merkel, Kurt D., Jeanne Erdmann, Kevin P. McHugh, et al.. (1999). Tumor Necrosis Factor-α Mediates Orthopedic Implant Osteolysis. American Journal Of Pathology. 154(1). 203–210. 327 indexed citations
14.
Tondravi, M. Mehrdad, Scott R. McKercher, Kenton L. Anderson, et al.. (1997). Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature. 386(6620). 81–84. 401 indexed citations
15.
Lacey, David L., et al.. (1995). Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages.. Endocrinology. 136(6). 2367–2376. 67 indexed citations
16.
Lacey, David L., Jeanne Erdmann, & Hong‐Lin Tan. (1994). Interleukin 4 increases type 5 acid phosphatase mrna expression in murine bone marrow macrophages. Journal of Cellular Biochemistry. 54(3). 365–371. 5 indexed citations
17.
Lacey, David L., et al.. (1994). Interleukin 4 enhances osteoblast macrophage colony-stimulating factor, but not interleukin 6, production. Calcified Tissue International. 55(1). 21–28. 14 indexed citations
18.
Lacey, David L., Jeanne Erdmann, Hong‐Lin Tan, & J Ohara. (1993). Murine osteoblast interleukin 4 receptor expression: Upregulation by 1,25 dihydroxyvitamin D3. Journal of Cellular Biochemistry. 53(2). 122–134. 19 indexed citations
19.
Lacey, David L., Jeanne Erdmann, & Hong‐Lin Tan. (1993). 1,25‐Dihydroxyvitamin D3 increases type 1 interleukin‐1 receptor expression in a murine T cell line. Journal of Cellular Biochemistry. 52(2). 159–170. 8 indexed citations
20.
Lacey, David L., Leonard E. Grosso, Stephen A. Moser, et al.. (1993). IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1,25 dihydroxyvitamin D3.. Journal of Clinical Investigation. 91(4). 1731–1742. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026